Accessibility settings

This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (eHealth) (1310) Neurology and Neurosciences (375) Cancer Survivorship (444) Clinical Cancer Research (236) Chemotherapy and Side Effects Management (143) Hearing Impairment and Hearing Loss (98)

Published on in Vol 14 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/71562, first published .
Hand holding a blue behind-the-ear hearing aid, with charging case

Comparative Study of the Quality of Life of Patients With Ototoxicity Due to Platinum-Based Chemotherapy, With Hearing Aid Versus Those Without: Study Protocol for a Randomized Pilot Study—The PROTOTOX Study

Comparative Study of the Quality of Life of Patients With Ototoxicity Due to Platinum-Based Chemotherapy, With Hearing Aid Versus Those Without: Study Protocol for a Randomized Pilot Study—The PROTOTOX Study

Authors of this article:

Romina Mastronicola1, 2 Author Orcid Image ;   Elise Kayser1 Author Orcid Image ;   Yolanda Fernandez1 Author Orcid Image ;   Gilles Dolivet1, 2 Author Orcid Image
Article Authors Cited by (1) Tweetations Metrics

Journals

  1. Kılıçtaş B, Kılıçtaş A, Erdem R, Oruç A, Araz M, Eryılmaz M, Kocak M, Arbağ H, Artaç M. Clinical and Social Determinants of Treatment Adherence in Cancer Patients: The Contributory Role of Hearing Loss. Laryngoscope Investigative Otolaryngology 2026;11(3) View